SCHEDULE 13G/A: Millennium Entities Disclose Amended Beneficial Ownership in Abeona Therapeutics
Beneficial Ownership Report
Millennium Management LLC and affiliated entities have filed an amended Schedule 13G, detailing their beneficial ownership of Abeona Therapeutics Inc. common stock as of March 31, 2025.
Summary
- Integrated Core Strategies (US) LLC beneficially owns 168,916 shares of Abeona Therapeutics Inc. Common Stock, representing 0.3% of the class.
- Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander each beneficially own 809,966 shares of Abeona Therapeutics Inc. Common Stock, representing 1.7% of the class.
- The filing is an Amendment No. 3 to a Schedule 13G, indicating a change or update to previously reported beneficial ownership.
- The reporting persons, including Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander, are affiliated entities and an individual acting as a group.
- The securities were not acquired and are not held for the purpose of changing or influencing the control of Abeona Therapeutics Inc.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would inherently lead to a positive or negative sentiment regarding the company's operational performance or future prospects. It is a neutral regulatory filing.
Positives
- Institutional investors, including Millennium Management LLC, hold a stake in Abeona Therapeutics Inc., indicating their investment interest in the company.
Future Outlook
NA
Industry Context
This filing is a routine disclosure of institutional ownership, providing transparency on significant holdings in a publicly traded company within the biotechnology or pharmaceutical sector (Abeona Therapeutics Inc.). It does not provide specific industry trends or competitive analysis.
Stakeholder Impact
- Shareholders may note the continued institutional interest in Abeona Therapeutics Inc. by Millennium Management and its affiliates.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of event requiring the filing of this statement (beneficial ownership snapshot date). |
| 04/30/2025 | Date of filing of this Schedule 13G Amendment No. 3. |
Keywords
Abeona Therapeutics, Millennium Management, Beneficial Ownership, Schedule 13G, SEC Filing, Institutional Ownership, Common Stock, Israel A. Englander
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.